Find an Eye MD near you!

Allergan Plc. has purchased AqueSys and its minimally invasive soft shunt for glaucoma, XEN45

Avedro has resubmitted a new drug application for its riboflavin opthalmic solution/KXL system for corneal cross-linking (CXL).

Dr. Sam Masket developed an IOL to prevent negative dysphotopsia, the dark or grey arc-shaped shadow seen in the temporal field of vision following uncomplicated cataract surgery.

The first clinical trial of an extended-release formulation of travoprost shows it’s comparable to topical once-daily travoprost in patients with glaucoma.

Alcon reports that the U.S. FDA has approved its AcrySof IQ aspheric IOL with the UltraSert pre-loaded delivery system.

A complete work-up immediately following nonarteritic central retinal artery occlusion picks up undiagnosed cardiovascular risk factors in almost 80% of patients.